Cholestan-3β,5α,6β-triol
CAS: 1253-84-5
Ref. 3D-FC76729
25mg | 173,00 € | ||
50mg | 233,00 € | ||
100mg | 351,00 € | ||
250mg | 549,00 € | ||
500mg | 802,00 € |
Informação sobre produto
- (3Beta,5Alpha,6Beta)-Cholestane-3,5,6-Triol
- (3Beta,5Alpha,6Beta,8Xi,9Xi,14Xi,17Xi,20Xi)-Cholestane-3,5,6-Triol
- (3β,5α,6β)-Cholestane-3,5,6-triol
- 3β,5α,6β-Trihydroxycholestane
- 3β-Hydroxycholestane-5α,6β-diol
- 5-Alpha-Cholestane-3-Beta,5,6-Beta-Triol
- 5α,6β-Dihydroxycholestanol
- 5α-Cholestane-3β,5,6β-triol
- Cholesta-3β,5α,6β-triol
- Cholestane-3,5,6-triol
- Ver mais sinónimos
- Cholestane-3,5,6-triol, (3β,5α,6β)-
- Cholestanetriol
- NSC 124751
- NSC 18178
- Cholestane-3β,5α,6β-triol
Cholestan-3b,5a,6b-triol is a naturally occurring fatty acid that has been shown to inhibit the synthesis of cholesterol and oxysterols in animal studies. It also acts as a receptor agonist for the LDL receptor. This compound is used in clinical trials to assess risk for cerebrotendinous xanthomatosis (CTX), a rare genetic disorder characterized by high levels of cholesterol and fatty acids in the brain and spinal cord. Cholestan-3b,5a,6b-triol is being studied as a potential treatment for atherosclerosis. The drug inhibits the uptake of cholesterol from macrophages and reduces the accumulation of atherosclerotic lesions in mouse models. Cholestan-3b,5a,6b-triol may be useful for treating patients with diabetes because it blocks the synthesis of fatty acids that can lead to diabetic complications such as retinopathy and nephropathy.
Propriedades químicas
Consulta técnica sobre: 3D-FC76729 Cholestan-3β,5α,6β-triol
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.